The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...

Highly organized LNPs may resist releasing their cargo due to interactions between the positively-charged lipids and negatively-charged RNA.

The tiny fatty capsules that deliver COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...

Moderna (MRNA) stock is in focus as BioNTech (BNTX) sues the biotech for allegedly violating patent linked to the rival shot developed with Pfizer (PFE). Read more here.

A new research paper was published in Volume 18 of Aging-US on February 8, 2026, titled "Single-cell transcriptomics reveal ...

The company revised its plan to seek full approval for middle-aged adults and accelerated approval for seniors.

BioNTech has filed a lawsuit against Moderna in a Delaware federal court over allegations of patent infringement related to ...

BioNTech has filed a lawsuit against Moderna in a Delaware federal court, claiming infringement on a patent related to their COVID-19 vaccine technology. Moderna's vaccine, mNEXSPIKE, allegedly ...

The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.

While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...